Centre Hospitalier Universitaire de NÄ«mes - Recruiting 18 years or older. - Prospective Randomized Trial Comparing Unilateral and Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder.
Unilateral electrode placement and testing; Bilateral electrode placement and testing
Ion Channel Innovations - Recruiting 18 years or older. - Phase 1 Double Blind, Placebo Controlled Study Assessing Safety and Activity Of 2 Escalating Doses of hMaxi-K Gene Transfer By Direct Injection Into the Bladder Wall In Female Subjects With OAB (Overactive Bladder Syndrome and Detrusor Overactivity).
Astellas Pharma Inc - Recruiting 18 years or older. - A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Combinations of Solifenacin Succinate and Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in the Treatment of Overactive Bladder.
University of Zurich - Recruiting 18 years to 55 years. - The Bladder and the Brain - Investigation of the Supraspinal Neural Control of Lower Urinary Tract Function in Healthy Subjects and Patients With Neurogenic and Non-neurogenic Bladder Dysfunction Using Advanced Neuroimaging Techniques.
Buddhist Tzu Chi General Hospital - Recruiting 20 years to 65 years. - Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder Syndrome - A Prospective Randomized Controlled Comparative Study With Mono-antimuscarinic Therapy.
Detrusitol 4mg QD and Oxybutynin ER 5mg QD; Detrusitol 4mg QD